Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases

News provided by

Mar 28, 2024, 11:30 ET

DUBLIN, March 28, 2024 /PRNewswire/ -- The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.

The global antibody therapeutic market is projected to experience remarkable growth to 2033

The escalating prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases has fueled the demand for antibody therapeutics. These treatments, designed to target specific antigens, are proving to be effective in managing and treating a wide range of medical conditions.

The global antibody therapeutic market occupies a pivotal role within the biopharmaceutical and life sciences sectors, dedicated to the manufacturing, advancement, and commercialization of antibodies with diverse applications in medical and research domains. These antibodies, or immunoglobulins, are essential proteins generated by the immune system, crucial for identifying and neutralizing harmful pathogens, toxins, and foreign substances.

Within the market context, antibodies are produced, modified, and applied for a spectrum of purposes, encompassing diagnostics, therapeutics, and research endeavors, spanning disease detection and treatment to laboratory experiments and pharmaceutical development. The expansion of the global antibody therapeutic markets was propelled by several influential factors. Primarily, the rising prevalence of chronic diseases and the escalating demand for targeted therapies have intensified the quest for innovative treatment modalities.

Key Questions Answered in this Report:

What are the growth opportunities for new entrants in the global antibody therapeutic sector?
Who are the primary players operating within the global antibody therapeutics market?
What key strategies are likely to be embraced by participants aiming to expand their share in the global antibody therapeutic industry?
How is the competitive landscape shaping up in the global antibody therapeutics market?
What emerging trends might impact the growth of the global antibody therapeutics market?
Which product type segment is anticipated to demonstrate a substantial CAGR in the future?
Which application segment is poised to capture a significant share in the global antibody therapeutic industry?
Which region presents lucrative opportunities for manufacturers in the global antibody therapeutics market?

Key Market Players:

AbbVie, Inc
Amgen Inc.
Johnson & Johnson Services, Inc.
Eli Lilly and Company
Hoffmann-La Roche Ltd.

Key Topics Covered:

1 Markets
1.1 Trends: Current and Future Impact Assessment
1.2 Supply chain Overview
1.2.1 Value Chain Analysis
1.2.2 Market Map
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Company)
1.4 Regulatory Landscape
1.5 Impact Analysis for Key Global Events - COVID-19
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.2 Market Restraints
1.6.3 Market Opportunities

2 Application
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Antibody Therapeutic Market (By Disease Area)
2.3.1 Autoimmune and Inflammatory Disease
2.3.2 Oncology
2.3.3 Haematology
2.3.4 Infectious Disease
2.3.5 Osteology
2.3.6 Immunology
2.3.7 Neurology
2.3.8 Others Disease Area
2.4 Global Antibody Therapeutic Market (By Route of Administration)
2.4.1 Intravenous
2.4.2 Subcutaneous
2.4.3 Others Route of Administration
2.5 Global Antibody Therapeutic Market (By End-User)
2.5.1 Hospitals
2.5.2 Long term Care Facilities
2.5.3 Others End-User

3 Products
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Antibody Therapeutic Market
3.3.1 Market Overview
3.3.1.1 Analyst View
3.4 Global Antibody Therapeutic Market (By Format)
3.4.1 Monoclonal Antibodies
3.4.2 Polyclonal Antibodies
3.4.3 Antibody Fragments
3.4.4 Bispecific Antibodies
3.4.5 Others Novel Antibody Therapies

4 Regions
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 U.S. Antibody Therapeutic Market by Application
4.3.8 Canada
4.3.9 Canada Antibody Therapeutic Market by Application
4.4 Europe
4.5 Asia Pacific
4.6 Rest-of-the-World (RoW)

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers
5.2 Geographic Assessment
5.2.1 Overview
5.2.2 Top Products / Product Portfolio
5.2.3 Top Competitors
5.2.4 Target Customers
5.2.5 Key Personnel
5.2.6 Analyst View
5.2.7 Market Share

Hoffmann-La Roche Ltd.
AbbVie, Inc
Amgen Inc.
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Regeneron Pharmaceuticals Inc.
Novartis AG
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline plc.
Takeda Pharmaceutical Company Ltd.
Abcam Plc.
Thermo Fisher Scientific, Inc
Cell Signaling Technology

For more information about this report visit https://www.researchandmarkets.com/r/sborjw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets